Breast cancer survivors must remain vigilant for recurrence signs, which can manifest locally, regionally, or distantly. New lumps, skin changes, nipple issues, and swollen lymph nodes are key ...

Mirla Avila and Susan Payrovi, MDs, explain MS progression, relapse vs. change, and subtle signs that matter even with a ...

"I felt like there would be no fixing the amount of pain I was in," Megan Jones, from the U.K., told Newsweek.

The best way to get off of antidepressants is gradually over months, with the support of a therapist, a new research review shows.

Lunsumio in combination with lenalidomide may offer an effective treatment in relapsed or refractory follicular lymphoma ...

Follow-up data from CARTITUDE-4 show at least 80 percent of as-treated standard-risk patients remained progression and treatment-free following a single infusion as early as second lineData suggest ...

Obe-cel demonstrates high remission rates in pediatric patients with high-risk r/r B-ALL with overall response rate (ORR) of 95.5%; low rates of high-grade cytokine release syndrome (CRS) and immune ...

Hardee Bhavsar ran her first marathon in November, five years after being diagnosed with lymphoma. She recalls the early ...

ALL is the most common childhood cancer, and cases are rising. Find out why this trend is paired with a remarkable 90% survival rate, and what public health action is needed next.

Bristol Myers Squibb (NYSE: BMY) reinforces its hematology leadership through new research across multiple therapies for patients with lymphoma at the 67th American Society of Hematology (ASH) Annual ...

Because AI chatbots often respond in a sycophantic manner that can mirror and build upon users’ beliefs with little or no disagreement, Morrin said in an interview with Scientific American, the effect ...

As the holidays draw near, eating more can be normal—but a doctor says these symptoms may signal it's time to seek help.